Korro Bio
KRRO | NASDAQ
$12.71
-$0.90 (-6.61%)
At close: Nov 16, 2026, 4:00 PM ET
$12.71
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Korro Bio Company Profile
Company profile explainedCompany Profile
Korro Bio, Inc., a biopharmaceutical firm based in Cambridge, Massachusetts, is dedicated to exploring, advancing, and bringing to market genetic therapeutics. These treatments are formulated through RNA editing technology, aiming to address a wide array of medical conditions, encompassing both uncommon and widespread diseases.
Key Executives
| Name | Position |
|---|---|
| Ram Aiyar | Chief Executive Officer, President, Interim Chief Financial Officer, Principal Financial Officer & Director |
| Stephanie Engels | Chief People Officer |
| Todd Chappell | Chief Operating Officer |
| Andrew Fraley | Co-Founder & Advisor |
| Gaozhong Zhu | SVP of Chemistry, Manufacturing and Controls & Technical Operations |
| Jean-Francois Formela | Co-Founder & Director |
| Jeffrey Cerio | Senior Vice President, General Counsel & Corporate Secretary |
| Joshua Rosenthal | Co-Founder & Advisor |
| Loic Vincent | Chief Scientific Officer |
| Oliver Dolan | Senior Vice President of Finance & Principal Accounting Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 27, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Oct 26, 2026 | 4 | Filing |
| Oct 22, 2026 | 8-K | Current Report |
| Oct 05, 2026 | 8-K | Current Report |
| Sep 15, 2026 | 4 | Filing |
| Sep 14, 2026 | 4 | Filing |
| Sep 10, 2026 | 4 | Filing |
| Aug 28, 2026 | 4 | Filing |
| Aug 21, 2026 | 4 | Filing |
| Aug 19, 2026 | 8-K | Current Report |
Korro Bio
| Country | United States |
| IPO Date | Oct 3, 2019 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 57 |
| CEO | Ram Aiyar |
Contact Details
60 First Street Cambridge,
Massachusetts 02141 United States
Stock Details
| Ticker Symbol | KRRO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001703647 |
| CUSIP Number | 500946108 |
| ISIN Number | US5009461089 |
| SIC Code | 2834 |
Add to Watchlist
Select watchlists to add or remove KRRO